Expression of Toll-like receptor 4 in neonatal cord blood mononuclear cells in patients with preeclampsia

Geqing Xia , Danfen Xu , Min Wu , Chaoying Wu

Current Medical Science ›› 2010, Vol. 30 ›› Issue (5) : 615 -619.

PDF
Current Medical Science ›› 2010, Vol. 30 ›› Issue (5) : 615 -619. DOI: 10.1007/s11596-010-0552-z
Article

Expression of Toll-like receptor 4 in neonatal cord blood mononuclear cells in patients with preeclampsia

Author information +
History +
PDF

Abstract

The expression of Toll-like receptor 4 (TLR4) in neonatal cord blood mononuclear cells (MNCs) and serum TNF-α were investigated in order to explore the roles of TLR4 in the pathogenesis of preeclampsia. The study enrolled 27 patients suffering from preeclampsia (experimental group) and 21 normal pregnancy patients (control group). After MNCs were separated, the expression of TLR4 mRNA and protein was detected by using real-time quantitative PCR and Western blotting respectively, and the expression of TNF-α by using ELISA. The results showed the TLR4 mRNA level in cord blood MNCs (2−ΔCT: 0.07±0.17), TLR4 protein expression level (absorbance ratio: 0.81%±0.15%) and TNF-α level (9.5±1.73 pg/mL) were all increased in experimental group as compared with control group with the differences being statistically significant (P<0.05). There was a positive correlation between the expression of TLR4 mRNA and TNF-± in both experimental group and control group (r=0.54 and 0.53, respectively, P<0.05). It was concluded that TLR4 expression in the experimental group of cord blood MNCs was increased and there was a positive correlation between the expression of TLR4 mRNA and TNF-α in both groups. TLR4-mediated release of inflammatory cytokines may be one of the important reasons leading to preeclampsia.

Keywords

preeclampsia / mononuclear cells / Toll-like receptor 4 / tumor necrosis factor α

Cite this article

Download citation ▾
Geqing Xia, Danfen Xu, Min Wu, Chaoying Wu. Expression of Toll-like receptor 4 in neonatal cord blood mononuclear cells in patients with preeclampsia. Current Medical Science, 2010, 30(5): 615-619 DOI:10.1007/s11596-010-0552-z

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

RedmanC.W., SargentI.L.. Latest advances in understanding preeclampsia. Science, 2005, 308(5728): 1592-1594

[2]

CudihyD., LeeR.V.. The pathophysiology of pre-eclampsia: Current clinical concepts. J Obstet Gynecol, 2009, 29(7): 576-582

[3]

RedmanC.W., SacksG.P., SargentI.L.. Preeclampsia: An excessive maternal inflammatory response to pregnancy. Am J Obstet Gynecol, 1999, 180(2): 499-506

[4]

RedlineR.W., PattersonP.. Preeclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol, 1995, 26(6): 594-600

[5]

RuslanM., PaulaP.H., CharlesA., et al.. A human homologue of the Drosophila Tol l protein signals activation of adaptive immunity. Nature, 1997, 388(6640): 394-397

[6]

WassermanS.A.. A conserved signal transduction pathway regulating the activity of rel-like proteins dorsal and NF-kappaB. Mol Biol Cell, 1993, 4(8): 767-771

[7]

BelvinM.P., AndersonK.V.. A conserved signaling pathway: The Drosophila Toll-dorsal pathway. Annu Rev Cell Dev Biol, 1996, 12: 393-416

[8]

ReisterF., FrankH.G., KingdomJ.C., et al.. Macro-phage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest, 2001, 81(8): 1143-1152

[9]

KokkinopoulosI., JordanW.J., RitterM.A.. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol Immunol, 2005, 42(8): 957-968

[10]

HoshinoK., TakeuchiO., KawaiT., et al.. Cutting edge: Toll-like receptor 4 (TLR4) deficient mice are hyporesponsive to lipopolysaccharide: Evidence for TLR4 as the LPS gene product. J Immunol, 1999, 162(7): 3749-3752

[11]

EquilsO., LuD., GatterM., et al.. Chlamydia heat shock protein 60 induces trophoblast apoptosis through TLR4. J Immunology, 2006, 177(2): 1257-1263

[12]

PaladinoN., LeoneM.J., PlanoS.A., et al.. Paying the circadian toll: The circadian response to LPS injection is dependent on the Toll-like receptor 4. J Neuroimmunol, 2010, 225(1): 62-67

[13]

MoffettA., LokeY.W.. The immunological paradox of pregnancy: A reappraisal. Placenta, 2004, 25(1): 1-8

[14]

Moffett-KingA.. Natural killer cells and pregnancy. Nat Rev Immunol, 2002, 2(9): 656-663

[15]

GuimondM.J., LurossJ.A., WangB., et al.. Absence of natural killer cells during murine pregnancy is associated with reproductive compromise in tgε26 mice. Biol Reprod, 1997, 56(1): 169-179

[16]

GuimondM.J., WangB., CroyB.A.. Engraftment of bone marrow from severe combined immunodeficient (SCID) mice reverses the reproductive deficits in natural killer cell-deficient tgε26 mice. J Exp Med, 1998, 187(2): 217-223

[17]

PollardJ.W., HuntJ.S., Wiktor-JedrzejczakW., et al.. A pregnancy defect in the osteopetrotic (op/op) mouse demonstrates the requirement for CSF-1 in female fertility. Dev Biol, 1991, 148(1): 273-283

[18]

KhanS., KatabuchiH., ArakiM., et al.. Human villous macrophage-conditioned media enhance human trophoblast growth and differentiation in vitro. Biol Reprod, 2000, 62(4): 1075-1083

[19]

von DadelszenP., MageeL.A.. Could an infectious trigger explain the differential maternal response to the shared placental pathology of preeclampsia and normotensive intrauterine growth restriction?. Acta Obstet Gynecol Scand, 2002, 81(7): 642-648

[20]

von DadelszenP., MageeL.A., KrajdenM., et al.. Levels of antibodies against cytomegalovirus and Chlamydop hila pneumoniae are increased in early onset pre-eclampsia. BJOG, 2003, 110(8): 725-730

[21]

Arechavaleta-VelascoF., KoiH., StraussJ.F.3rd, et al.. Viral infection of the trophoblast: Time to take a serious look at its role in abnormal implantation and placentation?. J Reprod Immunol, 2002, 55(1): 113-121

[22]

HsuC.D., WitterF.R.. Urogenital infection in preeclampsia. Int J Gynaecol Obstet, 1995, 49(3): 271-275

[23]

FaasM.M., SchuilingG.A., BallerJ.F., et al.. A new animal model for human preeclampsia: Ultra-low-dose endotoxin infusion in pregnant rats. Am J Obstet Gynecol, 1994, 171(1): 158-164

[24]

CiarmelaP., BoschiS., BloiseE., et al.. Polymorphisms of FAS and FAS ligand genes in preeclamptic women. Eur J Obstet Gynecol Reprod Biol, 2010, 148(2): 144-146

[25]

ButterworthB.H., Gree rI.A., ListonW.A., et al.. Immunocytochemical localization of neutrophil elastase in term placenta decidua and myometrium in pregnancy-induced hypertension. Br J Obstet Gynaecol, 1991, 98(9): 929-933

[26]

WilczynskiJ.R., TchorzewskiH., BanasikM., et al.. Lymphocyte subset distribution and cytokine secretion in third trimester decidua in normal pregnancy and preeclampsia. Eur J Obstet Gynecol Reprod Biol, 2003, 109(1): 8-15

[27]

AbrahamsV.M., KimY.M., StraszewskiS.L., et al.. Macrophages and apoptotic cell clearance during pregnancy. Am J Reprod Immunol, 2004, 51(4): 275-282

[28]

DengF., HanF., WuC.. Expression and immune effect of Toll-like receptor 4 in human trophoblast cells. J Huazhong Univ Sci Technol [Med Sci], 2009, 29(3): 359-364

[29]

KimY.M., RomeroR., OhS.Y., et al.. Toll-like receptor 4: A potential link between “danger signals,” the innate immune system, and preeclampsia?. Am J Obstet Gynecol, 2005, 193(3): 921-927

[30]

Velzing-AartsF.V., MuskietF.A., van der DijsF.P., et al.. High serum interleukin-8 levels in Afro-Caribbean women with pre-eclampsia. Relations with tumor necrosis factor-alpha, Duffy negative phenotype and von Willebrand factor. Am J Reprod Immunol, 2002, 48(5): 319-322

[31]

VinceG.S., StarkeyP.M., AustgulenR., et al.. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia. Br J Obstet Gynaecol, 1995, 102(1): 20-25

[32]

ConradK.P., MilesT.M., BenyoD.F.. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol, 1998, 40(2): 102-111

[33]

BauerS., PollheimerJ., HartmannJ., et al.. Tumor necrosis factor-alpha inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures. J Clin Endocrinol Metab, 2004, 89(2): 812-822

[34]

EstellesA., GilabertJ., GranchaS., et al.. Abnormal expression of type1 plasminogen activator inhibitor and tissue factor in severe preeclampsia. Thromb Haemost, 1998, 79(3): 500-508

AI Summary AI Mindmap
PDF

86

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/